Axsome Thera (AXSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 183,876 | 219,966 | 13,969 | 34,021 | 36,619 |
| TOTAL | $184,025 | $220,379 | $15,215 | $35,300 | $37,999 |
| Non-Current Assets | |||||
| PPE Net | 53 | 31 | 52 | 68 | 101 |
| Other Non-Current Assets | 2,057 | 140 | 112 | 188 | 113 |
| TOTAL | $2,110 | $171 | $164 | $256 | $214 |
| Total Assets | $186,134 | $220,550 | $15,379 | $35,556 | $38,213 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,504 | 10,943 | 3,687 | 3,436 | 4,081 |
| Accrued Expenses | 8,713 | 10,949 | 3,843 | 2,680 | 2,820 |
| Other current liabilities | N/A | N/A | N/A | 2,791 | N/A |
| TOTAL | $23,438 | $24,495 | $10,822 | $12,175 | $7,171 |
| Non-Current Liabilities | |||||
| Long Term Debt | 48,322 | 17,333 | 3,619 | 6,663 | 9,470 |
| Other Non-Current Liabilities | 582 | 0 | 0 | 0 | 0 |
| TOTAL | $48,904 | $17,333 | $3,619 | $6,663 | $9,470 |
| Total Liabilities | $72,341 | $41,827 | $14,441 | $18,838 | $16,641 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,405 | 37,075 | 33,280 | 25,493 | 19,196 |
| Common Shares | 4 | 4 | 3 | 3 | 2 |
| Retained earnings | -278,796 | -175,896 | -107,550 | -76,585 | -47,642 |
| TOTAL | $113,793 | $178,722 | $938 | $16,717 | $21,572 |
| Total Liabilities And Equity | $186,134 | $220,550 | $15,379 | $35,556 | $38,213 |